Cyclerion Therapeutics (NASDAQ:CYCN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network [Yahoo! Finance]
Cyclerion Therapeutics, Inc. (CYCN) Discusses On Pioneering A New Era In Neuropsychiatric Therapies Call (Transcript) [Seeking Alpha]
Cyclerion Therapeutics, Inc. - Pre Recorded Special Call [Seeking Alpha]
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company [Yahoo! Finance]